Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study

Acta Diabetologica

Volumn 51, Issue 5, 2014, Pages 783-791

  Bjornstad, Petter ^a,b   Maahs, David M ^a,b   Rivard, Christopher J ^b   Pyle, Laura ^a   Rewers, Marian ^a,b   Johnson, Richard J ^b   Snell Bergeon, Janet K ^a,b  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Macrovascular complications; Microvascular complications; Serum uric acid; Type 1 diabetes

Indexed keywords

CYSTATIN C; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; ALBUMINURIA; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; BLOOD; CALCINOSIS; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETIC ANGIOPATHIES; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; CALCINOSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; URIC ACID; YOUNG ADULT;

EID: 84919480535     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0611-1     Document Type: Article

References (45)

1. Forlenza GP, Rewers M (2011) The epidemic of type 1 diabetes: what is it telling us? Curr Opin Endocrinol Diabetes Obes 18(4):248–251. doi:10.1097/MED.0b013e32834872ce
2. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC (2013) The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 36(8):2271–2279. doi:10.2337/dc12-2258
3. Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, Hsueh W, Rewers M, Roberts BT, Savage PJ, Skarlatos S, Wassef M, Rabadan-Diehl C (2005) Report of the national heart, lung, and blood institute-national institute of diabetes and digestive and kidney diseases working group on cardiovascular complications of type 1 diabetes mellitus. Circulation 111(25):3489–3493. doi:10.1161/CIRCULATIONAHA.104.529651
4. Palmer LJ (1948) Medical and surgical vascular complications of diabetes. J Am Med Assoc 138(5):351–353; Disc, 355
5. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59(8):750–755
6. Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh epidemiology of diabetes complications study. Diabetologia 53(11):2312–2319. doi:10.1007/s00125-010-1860-3
7. Snell-Bergeon JK, Hokanson JE, Jensen L, MacKenzie T, Kinney G, Dabelea D, Eckel RH, Ehrlich J, Garg S, Rewers M (2003) Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care 26(10):2923–2928
8. Sipila K, Kahonen M, Salomaa V, Paivansalo M, Karanko H, Varpula M, Jula A, Kaaja R, Kesaniemi YA, Reunanen A, Moilanen L (2012) Carotid artery intima-media thickness and elasticity in relation to glucose tolerance. Acta Diabetol 49(3):215–223. doi:10.1007/s00592-011-0291-z
9. Salminen M, Kuoppamaki M, Vahlberg T, Raiha I, Irjala K, Kivela SL (2011) Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland. Acta Diabetol 48(2):157–165. doi:10.1007/s00592-010-0251-z
10. Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua A, Marini MA, Perticone F (2014) High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. doi:10.1007/s00592-014-0576-0
11. Bjornstad P, Snell-Bergeon JK, Rewers M, Jalal D, Chonchol MB, Johnson RJ, Maahs DM (2013) Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 36(11):3678–3683. doi:10.2337/dc13-0631
12. Bjornstad P, Snell-Bergeon JK, McFann K, Wadwa RP, Rewers M, Rivard CJ, Jalal D, Chonchol MB, Johnson RJ, Maahs DM (2013) Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes. J Diabetes Complications. doi:10.1016/j.jdiacomp.2013.12.007
13. Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK (2010) Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the coronary artery calcification in type 1 diabetes study. Nephrol Dial Transplant 25(6):1865–1869. doi:10.1093/ndt/gfp740
14. Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS (2010) High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 33(6):1337–1343. doi:10.2337/dc10-0227
15. Rodrigues TC, Maahs DM, Johnson RJ, Jalal DI, Kinney GL, Rivard C, Rewers M, Snell-Bergeon JK (2010) Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care 33(11):2471–2473. doi:10.2337/dc10-1007
16. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ (2005) Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 28(2):301–306
17. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367(1):20–29. doi:10.1056/NEJMoa1114248
18. Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH (2013) Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. doi:10.2337/dc13-0985
19. Maahs DM, Jalal D, McFann K, Rewers M, Snell-Bergeon JK (2011) Systematic shifts in cystatin C between 2006 and 2010. Clin J Am Soc Nephrol 6(8):1952–1955. doi:10.2215/CJN.11271210
20. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M (2004) Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol 182(5):1327–1332. doi:10.2214/ajr.182.5.1821327
21. Grassi MA, Mazzulla DA, Knudtson MD, Huang WW, Lee KE, Klein BE, Nicolae DL, Klein R (2009) Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy. Am J Ophthalmol 147(3):501–504. doi:10.1016/j.ajo.2008.09.016
22. Grassi MA, Sun W, Gangaputra S, Cleary PA, Hubbard L, Lachin JM, Gao X, Kiss S, Barkmeier AJ, Almony A, Davis M, Klein R, Danis RP (2013) Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy. Ophthalmology. doi:10.1016/j.ophtha.2013.06.002
23. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2):157–172. doi:10.1002/sim.2929; discussion 207–112
24. Pencina MJ, D’Agostino RB, Pencina KM, Janssens AC, Greenland P (2012) Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 176(6):473–481. doi:10.1093/aje/kws207
25. Pencina MJ, D’Agostino RB, Vasan RS (2010) Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 48(12):1703–1711. doi:10.1515/CCLM.2010.340
26. Leening MJ, Vedder MM, Witteman JC, Pencina MJ, Steyerberg EW (2014) Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician’s guide. Ann Intern Med 160(2):122–131
27. Fox CS, Gona P, Larson MG, Selhub J, Tofler G, Hwang SJ, Meigs JB, Levy D, Wang TJ, Jacques PF, Benjamin EJ, Vasan RS (2010) A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol 21(12):2143–2149. doi:10.1681/ASN.2010010085
28. Budoff MJ, Lane KL, Bakhsheshi H, Mao S, Grassmann BO, Friedman BC, Brundage BH (2000) Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 86(1):8–11
29. McEvoy JW (2010) Coronary artery calcium score and cardiovascular event prediction. J Am Med Assoc 304(7):741–742. doi:10.1001/jama.2010.1143; author reply 742
30. McEvoy JW, Blaha MJ, Defilippis AP, Budoff MJ, Nasir K, Blumenthal RS, Jones SR (2010) Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol 56(20):1613–1622. doi:10.1016/j.jacc.2010.06.038
31. Feig DI, Mazzali M, Kang DH, Nakagawa T, Price K, Kannelis J, Johnson RJ (2006) Serum uric acid: a risk factor and a target for treatment? J Am Soc Nephrol 17(4 Suppl 2):S69–S73. doi:10.1681/ASN.2005121331
32. Maahs DM, Caramori L, Cherney DZ, Galecki AT, Gao C, Jalal D, Perkins BA, Pop-Busui R, Rossing P, Mauer M, Doria A (2013) Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study. Curr Diab Rep. doi:10.1007/s11892-013-0381-0
33. Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH (2009) Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 58(7):1668–1671. doi:10.2337/db09-0014
34. Krizova L, Kalousova M, Kubena A, Benakova H, Zima T, Kovarik Z, Kalvoda J, Kalvodova B (2011) Increased uric acid and glucose concentrations in vitreous and serum of patients with diabetic macular oedema. Ophthalmic Res 46(2):73–79. doi:10.1159/000322994
35. Miyamoto M, Kotani K, Okada K, Fujii Y, Konno K, Ishibashi S, Taniguchi N (2012) The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. Acta Diabetol 49(1):63–68. doi:10.1007/s00592-011-0287-8
36. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2011) The diabetic cardiomyopathy. Acta Diabetol 48(3):173–181. doi:10.1007/s00592-010-0180-x
37. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, Johnson RJ (2003) Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 63(6):2088–2093
38. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA (2006) Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 17(6):1703–1709
39. Zhang J, Xiang G, Xiang L, Sun H (2014) Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus. J Endocrinol Invest. doi:10.1007/s40618-013-0034-9
40. Cicero AF, Salvi P, D’Addato S, Rosticci M, Borghi C (2014) Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella heart study. J Hypertens 32(1):57–64. doi:10.1097/HJH.0b013e328365b916
41. Myllymaki J, Honkanen T, Syrjanen J, Helin H, Rantala I, Pasternack A, Mustonen J (2005) Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 20(1):89–95
42. Basar N, Sen N, Ozcan F, Erden G, Kanat S, Sokmen E, Isleyen A, Yuzgecer H, Ozlu MF, Yildirimkaya M, Maden O, Covic A, Johnson RJ, Kanbay M (2011) Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Investig Med 59(6):931–937. doi:10.231/JIM.0b013e318214ebaf
43. Kanbay M, Sanchez-Lozada LG, Franco M, Madero M, Solak Y, Rodriguez-Iturbe B, Covic A, Johnson RJ (2011) Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant 26(2):430–437. doi:10.1093/ndt/gfq635
44. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, Ishimoto T, Sautin YY, Lanaspa MA (2013) Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62(10):3307–3315. doi:10.2337/db12-1814
45. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348(23):2285–2293. doi:10.1056/NEJMoa021835